What is COPD, Nucala for COPD treatment

FDA Approves Nucala for COPD Patients with High Eosinophil Levels

The U.S. Food and Drug Administration (FDA) has approved Nucala (mepolizumab) as an add-on treatment for adults with chronic obstructive pulmonary disease (COPD) who continue to have flare-ups despite using triple inhaled therapy. Nucala is the first biologic drug specifically approved for COPD patients with an “eosinophilic phenotype”—a group defined by having high levels of

RSV vaccine for seniors

New Study Shows RSV Vaccine Effective for Older Adults Over Three Seasons

A recent international study has found that a single dose of a new RSV vaccine, called RSVPreF3 OA, can protect adults aged 60 and older from serious lung infections caused by the respiratory syncytial virus (RSV) for up to three seasons.  The study involved over 24,000 older adults across 17 countries and tested how well

workplace coffee and cholesterol

Coffee Machines in Workplaces May Raise Cholesterol Levels, Study Finds

A recent study by Uppsala University and Chalmers University of Technology has found that coffee from many workplace coffee machines contains high levels of cholesterol-raising compounds. The research, published in Nutrition, Metabolism & Cardiovascular Diseases, highlights the difference between coffee brewed in these machines and coffee made using regular paper filter drip coffee makers.   

Semaglutide weight loss

Novo Nordisk’s Higher-Dose Semaglutide Shows Promising Weight Loss Results

Novo Nordisk is exploring a higher-dose version of semaglutide to enhance weight loss treatments. In a recent phase 3b clinical trial called STEP UP, a 7.2-mg weekly dose of semaglutide helped participants lose an average of 20.7% of their body weight over 72 weeks. This significantly outperformed the 2.4-mg dose marketed as Wegovy, which led